Theseus Pharmaceuticals, Inc. - stock earnings
Stock symbol THRX is outdated, potentially delisted? Maybe it is available on other exchange?
THRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -13.5 million USD | ? USD |
| 2023Q2 | -14.8 million USD | ? USD |
| 2023Q1 | -12.1 million USD | ? USD |
| 2022Q4 | -15.4 million USD | ? USD |
| 2022Q3 | -13.5 million USD | ? USD |
| 2022Q2 | -11.2 million USD | ? USD |
| 2022Q1 | -10.4 million USD | ? USD |
| 2021Q4 | -8.7 million USD | ? USD |
| 2021Q3 | -7.4 million USD | ? USD |
| 2021Q2 | -6.8 million USD | ? USD |
| 2021Q1 | -4.5 million USD | ? USD |
| 2020Q4 | -2.9 million USD | ? USD |
| 2020Q3 | -1.4 million USD | ? USD |
THRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -56.6 million USD | ? USD |
| 2022 | -47.1 million USD | ? USD |
| 2021 | -27.3 million USD | ? USD |
| 2020 | -12.0 million USD | ? USD |
| 2019 | -7.2 million USD | ? USD |
THRX
Price: $4.06
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.34 USD
P/E Ratio: -3.03
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 134600
Market Capitalization: 181.3 million
Average Dividend Frequency: 3